Cargando…
Cell Therapy of Severe Ischemia in People with Diabetic Foot Ulcers—Do We Have Enough Evidence?
This current opinion article critically evaluates the efficacy of autologous cell therapy (ACT) for chronic limb-threatening ischemia (CLTI), especially in people with diabetes who are not candidates for standard revascularization. This treatment approach has been used in ‘no-option’ CLTI in the las...
Autores principales: | Dubský, Michal, Husáková, Jitka, Sojáková, Dominika, Fejfarová, Vladimíra, Jude, Edward B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590286/ https://www.ncbi.nlm.nih.gov/pubmed/37740111 http://dx.doi.org/10.1007/s40291-023-00667-w |
Ejemplares similares
-
Comparison of the impact of autologous cell therapy and conservative standard treatment on tissue oxygen supply and course of the diabetic foot in patients with chronic limb-threatening ischemia: A randomized controlled trial
por: Dubský, Michal, et al.
Publicado: (2022) -
Endothelial Dysfunction in Diabetes Mellitus: New Insights
por: Dubsky, Michal, et al.
Publicado: (2023) -
Microdialysis as a tool for antibiotic assessment in patients with diabetic foot: a review
por: Fejfarová, Vladimíra, et al.
Publicado: (2023) -
The Effects of Immunosuppressive Drugs on the Characteristics and Functional Properties of Bone Marrow-Derived Stem Cells Isolated from Patients with Diabetes Mellitus and Peripheral Arterial Disease
por: Husakova, Jitka, et al.
Publicado: (2023) -
Stimulation TcPO2 Testing Improves Diagnosis of Peripheral Arterial Disease in Patients With Diabetic Foot
por: Fejfarová, Vladimíra, et al.
Publicado: (2021)